TBA-7371
TBA-7371 is an orally active and non-covalent inhibitor of Decaprenylphosphoryl-β-D-ribose oxidase (DprE1) of Mycobacterium tuberculosis (MIC=0.64 μg/mL). TBA-7371 can block the synthesis of arabinose in the bacterial cell wall, resulting in cell wall structural defects, thereby exerting an anti-tuberculosis effect. TBA-7371 can be used in the research of anti-tuberculosis drugs and has a synergistic bactericidal effect with Bedaquiline and other drugs[1][2][3].
Product Specifications
CAS Number
1494675-86-3
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/DprE1-IN-1.html
Purity
99.91
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(C1=CN(CC2=NC=NC(OC)=C2C)C3=CC(C)=CN=C31)NCCO
Molecular Formula
C18H21N5O3
Molecular Weight
355.39
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse VEGFB (Vascular endothelial growth factor B) ELISA Kit
Mouse VEGFB (Vascular endothelial growth factor B) ELISA Kit
Recombinant Treponema pallidum Apolipoprotein N-acyltransferase 1 (lnt1), partial
Recombinant Treponema pallidum Apolipoprotein N-acyltransferase 1 (lnt1), partial